None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Men and women, aged 19 to 65 years 2. Blood pressure is in the prehypertension stage or at stage 1 hypertension (systolic blood pressure of 120-159 mmHg or diastolic blood pressure of 80-99 mmHg) (by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria) 3. Provide consent to participate in this trial and sign an informed consent statement
Exclusion criteria
Exclusion criteria: 1. Taking medicine for blood pressure control, such as prescription or over the counter drug or herb/supplements 2. Secondary hypertension 3. Previous cerebrovascular or heart disease such as myocardial infarction, angina and valvular disease 4. Wasting disease 5. Insulin or diabetes medication in diabetic patients 6. Previous kidney, liver or hyperthyroidism 7. Active tuberculosis and other infectious disease 8. Systemic steroids or immunosuppressive therapy 9. Oral contraceptives, central nervous system inhibitors or stimulants, such as taking medication that affects blood pressure 10. Pregnant women, lactating and pregnant women who plan on 11. Others whose clinical trials conductors are considered inappropriate for participating in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The average systolic blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| Measure Yourself Medical Outcome Profile 2 (MYMOP2);The average systolic blood pressure ;The average diastolic blood pressure ;Body mass index (BMI);Lipid profile;Adverse events;Quality of life (EuroQol-5 Dimension, EQ-5D) | — |
Countries
Korea, Republic of
Contacts
Daejeon University